Yoshitaka Narita

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma

Maria-del-Mar Inda, Rudy Bonavia, Akitake Mukasa et al. · Genes & Development · 2010 · 541 citations · Full text

Medicine, Cancer Biology, Oncology +17

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

Hideyuki Arita, Yoshitaka Narita, Shintaro Fukushima et al. · Acta Neuropathologica · 2013 · 376 citations

Medicine, Genetics, Oncology +9

STAT6 Immunohistochemistry Is Helpful in the Diagnosis of Solitary Fibrous Tumors

Akihiko Yoshida, Koji Tsuta, Makoto Ohno et al. · The American Journal of Surgical Pathology · 2014 · 361 citations

Veterinary Medicine, Oncology, Pathology +13

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 265 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Recurrent mutations of <scp><i>CD79B</i></scp> and <scp><i>MYD88</i></scp> are the hallmark of primary central nervous system lymphomas

Taishi Nakamura, Kensuke Tateishi, T. Niwa et al. · Neuropathology and Applied Neurobiology · 2015 · 223 citations

Medicine, Molecular Genetics, Oncology +17